Company Recognized for Its Technological Approach to Personalized Medicine

    BURLINGTON, Mass., May 19 /PRNewswire/ -- ConforMIS, Inc., a privately
held company that develops and commercializes minimally invasive medical
devices for the treatment of osteoarthritis and joint damage, today
announced that is has been named a winner of the 2008 Red Herring North
America 100 Award. The award recognizes promising technology companies that
will lead the next wave of innovation.

    Red Herring award winners were selected based on criteria including
unique technology, experienced management team, strong customer base, solid
business model, key alliances and financial performance.

    ConforMIS has developed the first-ever personalized knee resurfacing
implants designed to conform precisely to a patient's knee. Using a
proprietary technology called iFit(TM) and data from a standard MR or CT
scan, ConforMIS creates minimally invasive, patient-specific implants that
offer unique advantages over a traditional knee replacement. Patients
benefit from superior fit, significant bone preservation, less trauma and
potentially faster recovery. Healthcare professionals benefit from a
simplified, reproducible surgical technique and radical reduction in the
number of surgical instruments that require handling and cleaning.

    "We're proud to be the recipients of this prestigious award," said
Philipp Lang, MD, chairman and CEO of ConforMIS. "We believe this
recognition by Red Herring only further validates the importance of our
patient-specific technology for knee replacements currently being offered
to the medical device industry. ConforMIS' image-to-implant technology
offers a truly innovative solution unique to each patient."

    The 100 winning companies were announced as part of the 11th Annual Red
Herring North America event on May 13, 2008. Past winners include companies
like Google, Yahoo!, eBay, Skype, YouTube, and Salesforce.com.

    "We can see the exciting evolution of the technology sector reflected
in the quality and variety of exceptional companies that we had to choose
from in putting our list together," said Joel Dreyfuss, editor-in-chief of
Red Herring. "It was tough to choose just 100 winners from such a large
list of excellent contenders, and we are very happy with the quality of the
companies we selected as finalists."

    To qualify for the award, companies must be a privately held technology
company headquartered in North America, and must not have been a previous
winner.

    About ConforMIS, Inc.

    ConforMIS, Inc. is a privately held company incorporated in 2004 that
develops and commercializes medical devices for the treatment of
osteoarthritis and joint damages. The Company's novel and scaleable
'image-to-implant' process is comprised of two related technology
platforms. iFit(TM) Technology enables the creation of conforming,
patient-specific implants that are precisely sized and shaped to match the
3D topography of the patient's anatomic bone surfaces. The iJig(TM)
Instrumentation enables the creation of novel disposable instrumentation
that radically simplifies and improves the surgical process.

    Both platforms are supported by proprietary, intellectual property
consisting of more than 120 issued, allowed and pending patents or patent
applications that span imaging software, image processing, implant design,
surgical techniques and instrumentation.

    To date, ConforMIS has developed a comprehensive line of minimally
traumatic, bone and cartilage-preserving knee implants and instrumentation
designed to address all stages of osteoarthritis, the most common reason
for knee replacement surgery. Each of these devices has been cleared by the
U.S. Food and Drug Administration for marketing in the U.S.



    ConforMIS, Inc. Contact:
    Jong Lee
    Senior Vice President, Marketing
    781-345-9107

    Media Contact:
    Sally Bain
    Racepoint Group
    781-487-4647
    sbain@racepointgroup.com

    This release was issued through eReleases(TM). For more information,
visit http://www.ereleases.com.

Link to this page: